This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Simulations Plus, Inc. designs, develops, and markets drug discovery and development software for mechanistic modeling and simulation.View SLP
Simulations Plus Inc - SLP - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Simulations Plus Inc as a
Buy with a ratings score of A.
Report Snippet: We rate SIMULATIONS PLUS INC (SLP) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, robust revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company shows weak operating cash flow.